uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Xervyteg
Opinion
Human
Details
EMA number
EMEA/H/C/006678
ATC code
-
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of adult patients with acute-graft-versus-host disease (aGvHD)
MeSH:
Graft vs Host Disease
Active substances
allogeneic faecal microbiota, pooled
Marketing Authorisation Holder
MaaT PHARMA
MAH
Xervyteg | uMedical